CSS LLC’s Milestone Pharmaceuticals MIST Stock Holding History

CSS LLC’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-98,900	Closed	-$392K	–	835
2022 Q4	$392K	Buy	98,900 +70,300	+246%	+$370K	0.02%	447
2022 Q3	$263K	Buy	28,600 +8,600	+43%	+$65.2K	0.01%	697
2022 Q2	$123K	Buy	+20,000	New	+$123K	0.01%	866

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CSS LLC's MIST Position: Q4 2022 in Review

CSS LLC sold out of Milestone Pharmaceuticals (MIST) in Q4 2022, closing a stake of 1,008 shares — an estimated $5.31K sold.

CSS LLC first reported a position in MIST in Q3 2022 and held it in 1 quarter. The position peaked at $9K in Q3 2022. 56 funds tracked by Wall St. Rank hold MIST as of Q4 2022.

CSS LLC reported no remaining Milestone Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
CSS LLC sold 1,008 Milestone Pharmaceuticals shares in Q4 2022, an estimated $5.31K.
CSS LLC first reported a position in Milestone Pharmaceuticals in Q3 2022 and held it in 1 quarter.
CSS LLC's Milestone Pharmaceuticals position peaked at $9K in Q3 2022.
56 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.